Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

NCT01602432 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT01602432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Lead sponsor
Ottawa Hospital Research Institute
Phase
Observational
Overall status
Withdrawn
Start date
November 30, 2012
Completion date
August 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, deep-vein thrombosis, pulmonary embolism, venous thromboembolism